Business Wire

Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel ...

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on developing advanced kinase inhibitor treatments targeting the tumor cell and the tumor ...
Business Wire

Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced the appointment of Kelley Dealhoy as Senior Vice President and Chief Business Officer. Ms. Dealhoy ...
腾讯网

Deciphera(DCPH.US)盘前大涨71% 获小野药品工业溢价收购

智通财经APP获悉，Deciphera Pharmaceuticals(DCPH.US)周一宣布，日本小野药品工业(OPHLY.US)已同意以24亿美元的总股本价值收购这家癌症药物开发商。受此消息提振，截至发稿，Deciphera 盘前大涨71%。 据悉，小野药品工业将通过要约收购方式，以每股25.60美元价格现金收购 ...
GlobalData on MSN

First patient dosed in Deciphera’s Phase III INTREPID study

The trial is enrolling in the US and will include regions in the Asia Pacific, Europe, Latin America, and North America.
Yahoo Finance

Deciphera to sell for $2.4B, adding to upswing in biopharma M&A

Ono Pharmaceutical has agreed to buy cancer drugmaker Deciphera Pharmaceuticals in a deal that values the latter company at $2.4 billion. \r Per deal terms, Ono is purchasing in cash all outstanding ...
Nasdaq

Deciphera (DCPH) Begins Dosing in Study on Cancer Candidate

Deciphera Pharmaceuticals, Inc. DCPH announced that it has dosed the first patient in a phase I study which is evaluating its investigational ULK kinase inhibitor, DCC-3116, for the treatment of ...
Reuters

Japan's Ono to buy US drugmaker Deciphera for $2.4 bln

April 29 (Reuters) - Deciphera Pharmaceuticals (DCPH.O), opens new tab said on Monday Japan's Ono Pharmaceutical Co (4528.T), opens new tab will acquire the cancer drugmaker for $2.4 billion to expand ...
Yahoo Finance

Deciphera Announces the Opening of a New Office in Zug, Switzerland

OSAKA, Japan & WALTHAM, Mass., November 17, 2025--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced the opening of a ...
The Motley Fool

Near a 2-Year Low, Is Deciphera Pharmaceuticals a Buy?

The company reported $42.1 million in revenue for 2020, up from $25 million in 2019. Qinlock (ripretinib) was responsible for most of that revenue, including $38 million in the U.S. and $1.5 million ...
新浪网

Deciphera盘前大涨71% 获小野药品工业溢价收购

Deciphera Pharmaceuticals(DCPH.US)周一宣布，日本小野药品工业(OPHLY.US)已同意以24亿美元的总股本价值收购这家癌症药物开发商。受此消息提振，截至发稿，Deciphera 盘前大涨71%。 据悉，小野药品工业将通过要约收购方式，以每股25.60美元价格现金收购Deciphera普通股的 ...
MarketWatch

Deciphera to be acquired by Japan’s Ono in all-cash deal valued at $2.4 billion

Deciphera Pharmaceuticals Inc. said Monday it has agreed to be acquired by Japan’s Ono Pharmaceutical Co. Ltd in an all-cash deal valued at $2.4 billion. Under the terms of the deal, Ono JP:4528 will ...